Midatech Receives Manufacturing License in Spain for its Nanoparticles
Midatech Biogune S. L., the nanoparticle manufacturing subsidiary of the Midatech Group, announced that it has been granted an Investigational Medicinal Products (IMP) License from the Spanish Medicines Agency for the cGMP manufacture of clinical grade nanoparticles at its state-of-the art facility in Bilbao, Spain.
Inspectors from the Spanish Medicines Agency carried out an inspection of the Midatech Biogune facility on the 15th and 16th of February 2011 and thereupon granted the accreditation, making Midatech one of the first companies in Spain to be granted this type of license under the new European regulations.
Justin Barry, CEO, said; "Getting such a rapid and positive response from the Medicines Agency validates the quality of our manufacturing and endorses the investment that Midatech has made into its first class quality systems.”
Other news from the department manufacturing
These products might interest you
NANOPHOX CS by Sympatec
Particle size analysis in the nano range: Analyzing high concentrations with ease
Reliable results without time-consuming sample preparation
Eclipse by Wyatt Technology
FFF-MALS system for separation and characterization of macromolecules and nanoparticles
The latest and most innovative FFF system designed for highest usability, robustness and data quality
DynaPro Plate Reader III by Wyatt Technology
Screening of biopharmaceuticals and proteins with high-throughput dynamic light scattering (DLS)
Efficiently characterize your sample quality and stability from lead discovery to quality control
Most read news
More news from our other portals
Last viewed contents
AstraZeneca Announces $100 Million R&D Investment in China - New Innovation Centre to Focus Initially on Oncology Research
Surprising discovery could lead to better batteries
Dow acquires Rohm and Haas, creating world's leading specialty chemicals and advanced materials company - $18.8 billion transaction marks pivotal point in Dow's transformation
Small change for a big improvement – halogen bonds and drug discovery
Texere Publishing Ltd. - Knutsford, United Kingdom
Univar Solutions B.V. - Rotterdam, Netherlands
Blockbusters Going off Patent - Opportunities for Generics - Growing Demand for Inexpensive, Effective Drugs and Continuing Patent Expiries ProvideGrowth Prospects for the European Generics Market
Rohm and Haas announces price increase for methacrylate monomers
Making plastic recycling more efficient - Klaus Feichtinger and Manfred Hackl named European Inventor Award 2019 finalists
Watching the charge move in photoexcited molecules - Research opens up the possibility to map the charge flowing inside the molecular landscape
LANXESS expands capacity of microbial active ingredient Preventol CMK by 50 percent - Long-term trend towards more disinfection
